NYSE:NBY NovaBay Pharmaceuticals (NBY) Stock Forecast, Price & News $0.48 +0.01 (+2.14%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$0.44▼$0.4950-Day Range N/A52-Week Range$0.42▼$4.38Volume164,088 shsAverage Volume3.38 million shsMarket Capitalization$2.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media About NovaBay PharmaceuticalsNovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.Read More NBY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBY Stock News HeadlinesSeptember 20, 2023 | americanbankingnews.comNovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.comSee More Headlines Receive NBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address NBY Company Calendar Last Earnings8/10/2023Today9/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:NBY CUSIPN/A CIK1389545 Webnovabay.com Phone510-899-8800Fax510-474-1577Employees29Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($9.9465) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,610,000.00 Net Margins-79.70% Pretax Margin-79.70% Return on Equity-146.20% Return on Assets-69.63% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.25 Sales & Book Value Annual Sales$14.40 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book0.12Miscellaneous Outstanding Shares4,210,000Free Float4,160,000Market Cap$2.01 million OptionableNot Optionable Beta2.82 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Justin M. Hall Esq. (Age 45)Pres, CEO, Gen. Counsel, Chief Compliance Officer, Corp. Sec. & Director Comp: $364.95kDr. Audrey Kunin M.D. (Age 64)Chief Product Officer Comp: $204.4kMr. Tommy Law (Age 37)Controller, Interim CFO & Treasurer Dr. Jeffrey Kunin M.D. (Age 60)Pres of DERMAdoctor Key CompetitorsAltamira TherapeuticsNASDAQ:CYTOAyala PharmaceuticalsNASDAQ:ADXSScopus BioPharmaNASDAQ:SCPSAllarity TherapeuticsNASDAQ:ALLRInfinity PharmaceuticalsNASDAQ:INFIView All Competitors NBY Stock - Frequently Asked Questions How have NBY shares performed in 2023? NovaBay Pharmaceuticals' stock was trading at $0.5450 at the beginning of the year. Since then, NBY stock has decreased by 12.3% and is now trading at $0.4780. View the best growth stocks for 2023 here. How were NovaBay Pharmaceuticals' earnings last quarter? NovaBay Pharmaceuticals, Inc. (NYSE:NBY) posted its quarterly earnings results on Thursday, August, 10th. The company reported ($1.27) earnings per share for the quarter. The business earned $4.61 million during the quarter. NovaBay Pharmaceuticals had a negative net margin of 79.70% and a negative trailing twelve-month return on equity of 146.20%. What other stocks do shareholders of NovaBay Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include OpGen (OPGN) and Abbott Laboratories (ABT). What is NovaBay Pharmaceuticals' stock symbol? NovaBay Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "NBY." How do I buy shares of NovaBay Pharmaceuticals? Shares of NBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NovaBay Pharmaceuticals' stock price today? One share of NBY stock can currently be purchased for approximately $0.48. How much money does NovaBay Pharmaceuticals make? NovaBay Pharmaceuticals (NYSE:NBY) has a market capitalization of $2.01 million and generates $14.40 million in revenue each year. The company earns $-10,610,000.00 in net income (profit) each year or ($9.9465) on an earnings per share basis. How can I contact NovaBay Pharmaceuticals? NovaBay Pharmaceuticals' mailing address is 2000 Powell Street, Suite 1150, eleventh floor, EmeryVille, CA 94608, United States. The official website for the company is novabay.com. The company can be reached via phone at 510-899-8800, via email at jcain@lhai.com, or via fax at 510-474-1577. This page (NYSE:NBY) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.